These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
723 related articles for article (PubMed ID: 34446045)
1. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045 [TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern. Xue Z; Nuerrula Y; Sitiwaerdi Y; Eli M Biomol Biomed; 2024 May; 24(3):545-559. PubMed ID: 38340316 [TBL] [Abstract][Full Text] [Related]
3. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance. Wang Z; Zhang J; Li M; Kong L; Yu J Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241 [TBL] [Abstract][Full Text] [Related]
4. EZH2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC. Yu Y; MohamedAl-Sharani H; Zhang B Oral Dis; 2023 Apr; 29(3):880-891. PubMed ID: 34614259 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172 [TBL] [Abstract][Full Text] [Related]
6. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis. Gao Y; Wan L; Li M; Wang B; Ma Y Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528 [TBL] [Abstract][Full Text] [Related]
7. HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis. Yang JY; Lei XY; He KY; Guo JR; Liu MJ; Li JQ; Li QT; Jiang ZH; Zhang L; Wu DH; Li YJ; Sun QH; Jian YP; Xu ZX Cell Death Dis; 2024 Feb; 15(2):158. PubMed ID: 38383528 [TBL] [Abstract][Full Text] [Related]
8. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy. Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925 [TBL] [Abstract][Full Text] [Related]
9. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865 [TBL] [Abstract][Full Text] [Related]
10. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway. Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283 [TBL] [Abstract][Full Text] [Related]
11. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis. Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213 [TBL] [Abstract][Full Text] [Related]
12. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study. Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma. Gao Y; Li M; Wang B; Ma Y Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130 [TBL] [Abstract][Full Text] [Related]
14. [Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis]. Wang Y; Zhang P Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1389-1396. PubMed ID: 39051085 [TBL] [Abstract][Full Text] [Related]
15. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma. Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627 [TBL] [Abstract][Full Text] [Related]
16. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Dong H; Qiang Z; Chai D; Peng J; Xia Y; Hu R; Jiang H Aging (Albany NY); 2020 Jun; 12(13):12943-12959. PubMed ID: 32601262 [TBL] [Abstract][Full Text] [Related]
17. Nrf2 and its dependent autophagy activation cooperatively counteract ferroptosis to alleviate acute liver injury. Liu J; Huang C; Liu J; Meng C; Gu Q; Du X; Yan M; Yu Y; Liu F; Xia C Pharmacol Res; 2023 Jan; 187():106563. PubMed ID: 36410674 [TBL] [Abstract][Full Text] [Related]
18. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma. Huang S; Zhang J; Li Y; Xu Y; Jia H; An L; Wang X; Yang Y J Transl Med; 2023 Jun; 21(1):379. PubMed ID: 37303041 [TBL] [Abstract][Full Text] [Related]
20. A novel link between circPDE3B and ferroptosis in esophageal squamous cell carcinoma progression. Zhou P; Wu Z; Zhang Q; Wang L; Zhang W; Han X Genomics; 2024 Jan; 116(1):110761. PubMed ID: 38092323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]